A breast CT scanner dedicated to diagnostic applications could be on the market by the end of this year. The clinical test unit, unveiled today at the University of Rochester Medical Center, NY, has already scanned several patients and will soon begin a 60-patient study to compare its images with those obtained using conventional mammography systems.
A breast CT scanner dedicated to diagnostic applications could be on the market by the end of this year. The clinical test unit, unveiled today at the University of Rochester Medical Center, NY, has already scanned several patients and will soon begin a 60-patient study to compare its images with those obtained using conventional mammography systems. Cases will include normals and proven cancers. A final system design will debut at the 2006 RSNA meeting.
John H. Neugebauer, CEO of Koning Corporation, based in Rochester, believes the precedents set by CT and other modalities will allow the company to sidestep the intensive regulatory process that digital mammography systems must undergo, allowing speedy commercialization of the product.
CT is being used to visualize the whole body and specific body parts, as in the case of dedicated CTs for dental, head, and surgical applications, he said. MR has gone from general to breast-specific imaging in the case of a dedicated unit made by Aurora Imaging Technology. PET has done the same with a dedicated breast imager from Naviscan PET Systems. All have been cleared through the FDA's 510(k) process.
"We hope it goes in this direction for market clearance," Neugebauer told DI SCAN. "But it's up to the FDA, not us."
Product labeling will make a big difference. Neugebauer said the company will market the system as a diagnostic, rather than as a screening tool. This should help make the case for 510(k) clearance, he said.
A commercial system will be pricey, about $800,000. But maintenance will amount to only about half the upkeep cost for general-purpose CTs, however, as the Koning system relies on a standard mammography x-ray tube.
Koning's cone-beam CT sports a unique horizontal gantry into which a single, uncompressed breast is suspended. A 30 x 40-cm flat-panel detector rotates once around the breast as the tube pulses x-rays. (Both the tube and flat panel are being supplied by Varian Medical.) Cone-beam algorithms reconstruct the data into a volumetric image of the breast.
"The first images we have seen are exactly what we want them to be," Neugebauer said. "I can't say we hit a home run right out of the box, but we certainly got to third."
Dose will be approximately equivalent to a two-view mammogram, he said. Unlike conventional CTs, chest tissue other than the breast largely avoids x-ray exposure, thanks to the horizontal gantry.
Breast scans will be performed in 10 seconds or less. A high-resolution mode may also be available, and will require scans twice as long.
Images will be presented in 2D multislice, multiplanar, and 3D formats. A later version of the device, due for market about a year after the first, will support stereotactic biopsy. Both configurations are being designed to fit into a room no bigger than one needed to house a mammography system.
The approach taken by Koning is similar to that for breast tomosynthesis, whereby a digital mammography system takes multiple exposures across an arc of a compressed breast. Hologic, GE, and Siemens are each developing such units. Koning's system differs, however, in that it makes a full 360° turn around the breast, capturing an entire volume and creating truly isotropic voxels, which are equal in size in all planes, according to Neugebauer.
"This leads to very high spatial resolution," Neugebauer said.
Although optimized for breast imaging, the cone-beam scanner might also be used to scan extremities, including hands and feet. The FDA submission will likely include these indications, he said.
The scanner is based on research conducted by Ruolo Ning and colleagues at the University of Rochester. Ning, a professor of radiology, founded Koning on patents derived from this early work and licensed from the university. Two relate specifically to breast applications and address the apparatus and method, prone position, gantry under the table, and algorithm for reconstructing images. Others address applications in angiography and lung cancer screening.
Neugebauer expects to develop niche scanners for these other applications, although these systems are at least five years from market.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.